Graviton Bioscience
Rui Wu, Ph.D. is currently the SVP, Head of Research & Preclinical and Chief CMC Officer at Graviton Bioscience. Previously, Rui Wu held positions such as Senior Director of Neuroscience at MeiraGTx, Senior Vice President of Preclinical and Pharmaceutical Operations at Équilibre BioPharmaceuticals Corp., and worked as a Postdoc at Weill Cornell Medicine. Rui Wu has a Ph.D. in Chemistry and Biochemistry from Loyola University Chicago and has a Bachelor's Degree in Chemistry from Sichuan University.
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.